Result of Everolimus Treatment on Fibrosis Progression in Maintenance Liver Transplant Patients with Recurrent Hepatitis C

被引：0
|
作者：
Villamil, F. [1 ]
Gadano, A. [2 ]
Zingale, F. [3 ]
Perez, R. [4 ]
Gil, O. [10 ]
Yantorno, S. [5 ]
Mastai, R. [6 ]
Otero, A. [7 ]
Dong, G. [8 ]
Lopez, P. [9 ]
机构：
[1] British Hosp Buenos Aires, Liver Transplant Unit, Buenos Aires, DF, Argentina
[2] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina
[3] Inst Cardiovasc Rosario, Rosario, Argentina
[4] Hosp Italiano Mendoza, Mendoza, Argentina
[5] Fdn Favaloro, Buenos Aires, DF, Argentina
[6] Hosp Aleman, Buenos Aires, DF, Argentina
[7] Novartis Pharmaceut, Buenos Aires, DF, Argentina
[8] Novartis Pharmaceut, E Hanover, NJ USA
[9] Novartis Pharma AG, Basel, Switzerland
[10] Hepato Gastronterol, Cordoba, Argentina
来源：
TRANSPLANTATION | 2012年 / 94卷 / 10期
关键词：
D O I：
10.1097/00007890-201211271-00014
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
1575
引用
收藏
页码：9 / 9
页数：1
相关论文
共 50 条
  • [1] Effect of Everolimus on Fibrosis Progression in Liver Transplant Patients with Recurrent Hepatitis C - Results from the REVERT Study.
    Villamil, F.
    Gadano, A.
    Zingale, F.
    Perez, R.
    Gil, O.
    Yantorno, S.
    Otero, A.
    Wang, Y.
    Lopez, P.
    Mastai, R.
    LIVER TRANSPLANTATION, 2012, 18 : S98 - S99
  • [2] Fibrosis progression in maintenance liver transplant patients with hepatitis C recurrence: a randomised study of everolimus vs. calcineurin inhibitors
    Villamil, Federico G.
    Gadano, Adrian C.
    Zingale, Fernanda
    Perez, Roberto
    Gil, Octavio
    Yantorno, Silvina
    Mastai, Ricardo
    Cairo, Fernando O.
    Otero, Alcira B.
    Dong, Gaohong
    Lopez, Patricia
    LIVER INTERNATIONAL, 2014, 34 (10) : 1513 - 1521
  • [3] Maintenance ribavirin monotherapy delays fibrosis progression in liver transplant recipients with recurrent hepatitis C at high risk of progression
    Lionetti, Raffaella
    Tisone, Giuseppe
    Palmieri, Giampiero
    Almerighi, Cristiana
    Anselmo, Alessandra
    Tariciotti, Laura
    Lenci, Ilaria
    De Luca, Linda
    Monaco, Andrea
    Angelico, Mario
    DIGESTIVE AND LIVER DISEASE, 2010, 42 (04) : 297 - 303
  • [4] Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C
    Manzia, Tommaso Maria
    Angelico, Roberta
    Toti, Luca
    Bellini, Maria Irene
    Sforza, Daniele
    Palmieri, Giampiero
    Orlando, Giuseppe
    Tariciotti, Laura
    Angelico, Mario
    Tisone, Giuseppe
    TRANSPLANT INTERNATIONAL, 2011, 24 (05) : 461 - 468
  • [5] Fibrosis progression after liver transplantation in patients with recurrent hepatitis C
    Walter, T.
    Dumortier, J.
    Scoazec, J.
    Boillot, O.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S181 - S181
  • [6] Fibrosis progression after liver transplantation in patients with recurrent hepatitis C
    Neumann, UP
    Berg, T
    Harren, M
    Langrehr, JM
    Neuhaus, P
    LIVER TRANSPLANTATION, 2003, 9 (06) : C33 - C33
  • [7] Fibrosis progression after liver transplantation in patients with recurrent hepatitis C
    Feray, C
    JOURNAL OF HEPATOLOGY, 2004, 41 (05) : 862 - 863
  • [8] Antiviral maintenance with interferon and ribavrin liver transplant patients with recurrent hepatitis C - Impact on fibrosis progression and long-term survival.
    Arno, K
    Katharina, T
    Bernadette, K
    Andrea, T
    Rigo, V
    Utz, S
    LIVER TRANSPLANTATION, 2005, 11 (07) : C3 - C3
  • [9] Progression of fibrosis and interferon treatment in liver transplant recipients with hepatitis C infection
    Habib, Shahid
    Chang, Chung-Chou H.
    Ahmad, Jawad
    Sass, David
    Shaw-Stiffel, Thomas
    Demetris, Anthony J.
    De Vera, Michael
    Fontes, Paulo
    Marcos, Amadeo
    Shaikh, Obaid S.
    HEPATOLOGY, 2006, 44 (04) : 320A - 320A
  • [10] Fibrosis progression after liver transplantation in patients with recurrent hepatitis C.
    Neumann, UP
    Berg, T
    Neuhaus, P
    HEPATOLOGY, 2003, 38 (04) : 227A - 227A
12345